Чланци са овлашћеним јавним приступом - Clifford LeenСазнајте више
Није доступно нигде: 3
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
SMART Study Group*
Annals of internal medicine 149 (5), 289-299, 2008
Овлашћења: US National Institutes of Health
End-stage kidney disease and kidney transplantation in HIV-positive patients: an observational cohort study
E Gathogo, S Jose, R Jones, JB Levy, NE Mackie, J Booth, J Connolly, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 67 (2), 177-180, 2014
Овлашћења: UK Medical Research Council
Molecular and epidemiological evidence of patient-to-patient hepatitis C virus transmission in a Scottish emergency department
I Johannessen, J Danial, DB Smith, J Richards, L Imrie, A Rankin, ...
Journal of Hospital Infection 98 (4), 412-418, 2018
Овлашћења: Wellcome Trust
Доступно негде: 74
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
Овлашћења: Danish National Research Foundation, National Institute for Health Research, UK
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
MT May, M Gompels, V Delpech, K Porter, C Orkin, S Kegg, P Hay, ...
Aids 28 (8), 1193-1202, 2014
Овлашћења: UK Medical Research Council
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
Овлашћења: US National Institutes of Health
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
Овлашћења: Swiss National Science Foundation, US National Institutes of Health
British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow …
Writing Group, I Williams, D Churchill, J Anderson, M Boffito, M Bower, ...
HIV medicine 15, 1-6, 2014
Овлашћења: UK Medical Research Council
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV …
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1145-1155, 2008
Овлашћења: US National Institutes of Health
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure
S Jose, L Hamzah, LJ Campbell, T Hill, M Fisher, C Leen, R Gilson, ...
The Journal of infectious diseases 210 (3), 363-373, 2014
Овлашћења: UK Medical Research Council, National Institute for Health Research, UK
Infection‐related and‐unrelated malignancies, HIV and the aging population
L Shepherd, ÁH Borges, B Ledergerber, P Domingo, A Castagna, ...
HIV medicine 17 (8), 590-600, 2016
Овлашћења: Swiss National Science Foundation
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study
RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ...
The Lancet 376 (9738), 340-345, 2010
Овлашћења: US National Institutes of Health
Antiretrovirals, fractures, and osteonecrosis in a large international HIV cohort
ÁH Borges, J Hoy, E Florence, D Sedlacek, HJ Stellbrink, V Uzdaviniene, ...
Clinical Infectious Diseases 64 (10), 1413-1421, 2017
Овлашћења: Swiss National Science Foundation, Danish National Research Foundation
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe
A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ...
The Journal of infectious diseases 207 (8), 1216-1220, 2013
Овлашћења: Research Foundation (Flanders), UK Medical Research Council
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
D Churchill, L Waters, N Ahmed, B Angus, M Boffito, M Bower, D Dunn, ...
HIV medicine 17 (S4), S2-S104, 2016
Овлашћења: UK Medical Research Council, National Institute for Health Research, UK
Hepatitis B, hepatitis C, and mortality among HIV-positive individuals
AC Thornton, S Jose, S Bhagani, D Chadwick, D Dunn, R Gilson, J Main, ...
Aids 31 (18), 2525-2532, 2017
Овлашћења: UK Medical Research Council
Clinical characteristics and outcomes of HIV-associated immune complex kidney disease
JW Booth, L Hamzah, S Jose, C Horsfield, P O'Donnell, S McAdoo, ...
Nephrology Dialysis Transplantation 31 (12), 2099-2107, 2016
Овлашћења: UK Medical Research Council, National Institute for Health Research, UK
Neurocognitive function in HIV infected patients on antiretroviral therapy
A Winston, A Arenas-Pinto, W Stöhr, M Fisher, CM Orkin, K Aderogba, ...
PloS one 8 (4), e61949, 2013
Овлашћења: US National Institutes of Health, UK Medical Research Council
High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies
CP Sharp, A Lail, S Donfield, R Simmons, C Leen, P Klenerman, ...
The Journal of infectious diseases 200 (7), 1119-1125, 2009
Овлашћења: US National Institutes of Health
British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.
E Wilkins, M Nelson, K Agarwal, D Awoyemi, E Barnes, S Bhagani, ...
HIV medicine 14, 2013
Овлашћења: UK Medical Research Council
Публикације и информације о финансирању аутоматски одређује рачунарски програм